| Dr Jason Paul Mora, DO | |
|
994 W Sherman Ave, Vineland, NJ 08360-6937 | |
| (609) 267-9400 | |
| Not Available |
| Full Name | Dr Jason Paul Mora |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 994 W Sherman Ave, Vineland, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184036071 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 25MB10816200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada At Inspira, Home Health And Hospice | Millville, NJ | Home health agency |
| Bayada Home Health Care, Inc | Cherry hill, NJ | Home health agency |
| Inspira Medical Center Elmer | Elmer, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Inspira Medical Center Vineland | Vineland, NJ | Hospital |
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
Hovione and Dickstein Shapiro LLP are pleased to announce that the U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten analogue, two key intermediates on the synthesis of fluticasone, an important corticosteroid used in asthma medications, reversing a rejection by the reexamination examiner.
"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.
The Special Committee of Independent Directors of Patheon Inc. today announced that Lonza Group AG ("Lonza") has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of the Company. In addition, the Special Committee and Lonza have mutually agreed to terminate discussions regarding other possible strategic transactions between Lonza and Patheon.
Nursing homes that rely the most on Medicaid tend to provide the worst care for their residents — not just the people covered by the program but also those who pay privately or have Medicare coverage.
› Verified 3 days ago
| Entity Name | Reconstructive Orthopedics, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659319002 PECOS PAC ID: 4183726144 Enrollment ID: O20070221000397 |
News Archive
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
Hovione and Dickstein Shapiro LLP are pleased to announce that the U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten analogue, two key intermediates on the synthesis of fluticasone, an important corticosteroid used in asthma medications, reversing a rejection by the reexamination examiner.
"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.
The Special Committee of Independent Directors of Patheon Inc. today announced that Lonza Group AG ("Lonza") has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of the Company. In addition, the Special Committee and Lonza have mutually agreed to terminate discussions regarding other possible strategic transactions between Lonza and Patheon.
Nursing homes that rely the most on Medicaid tend to provide the worst care for their residents — not just the people covered by the program but also those who pay privately or have Medicare coverage.
› Verified 3 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
Hovione and Dickstein Shapiro LLP are pleased to announce that the U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten analogue, two key intermediates on the synthesis of fluticasone, an important corticosteroid used in asthma medications, reversing a rejection by the reexamination examiner.
"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.
The Special Committee of Independent Directors of Patheon Inc. today announced that Lonza Group AG ("Lonza") has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of the Company. In addition, the Special Committee and Lonza have mutually agreed to terminate discussions regarding other possible strategic transactions between Lonza and Patheon.
Nursing homes that rely the most on Medicaid tend to provide the worst care for their residents — not just the people covered by the program but also those who pay privately or have Medicare coverage.
› Verified 3 days ago
| Entity Name | Cpa Care Of Penn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679036339 PECOS PAC ID: 1557799285 Enrollment ID: O20210413001501 |
News Archive
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
Hovione and Dickstein Shapiro LLP are pleased to announce that the U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten analogue, two key intermediates on the synthesis of fluticasone, an important corticosteroid used in asthma medications, reversing a rejection by the reexamination examiner.
"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.
The Special Committee of Independent Directors of Patheon Inc. today announced that Lonza Group AG ("Lonza") has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of the Company. In addition, the Special Committee and Lonza have mutually agreed to terminate discussions regarding other possible strategic transactions between Lonza and Patheon.
Nursing homes that rely the most on Medicaid tend to provide the worst care for their residents — not just the people covered by the program but also those who pay privately or have Medicare coverage.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Paul Mora, DO 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: () - | Dr Jason Paul Mora, DO 994 W Sherman Ave, Vineland, NJ 08360-6937 Ph: (609) 267-9400 |
News Archive
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
Hovione and Dickstein Shapiro LLP are pleased to announce that the U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten analogue, two key intermediates on the synthesis of fluticasone, an important corticosteroid used in asthma medications, reversing a rejection by the reexamination examiner.
"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.
The Special Committee of Independent Directors of Patheon Inc. today announced that Lonza Group AG ("Lonza") has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of the Company. In addition, the Special Committee and Lonza have mutually agreed to terminate discussions regarding other possible strategic transactions between Lonza and Patheon.
Nursing homes that rely the most on Medicaid tend to provide the worst care for their residents — not just the people covered by the program but also those who pay privately or have Medicare coverage.
› Verified 3 days ago
Dr. Andrew James Mostello, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 352 S Delsea Dr Unit C, Vineland, NJ 08360 Phone: 856-690-1616 Fax: 856-896-6107 | |
Joseph Philip Bernardini, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 994 West Sherman Ave, Vineland, NJ 08360 Phone: 856-696-0900 Fax: 856-692-4769 | |
Dr. Rahul V Shah, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 352 S Delsea Dr Ste C, Vineland, NJ 08360 Phone: 856-690-1616 | |
Elizabeth Ford, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1505 W Sherman Ave, Vineland, NJ 08360 Phone: 856-641-8000 | |
Dr. John David Jennings, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 994 W Sherman Ave, Vineland, NJ 08360 Phone: 609-267-9400 | |
Dr. Robert Paul Falconiero, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 352 S Delsea Dr Unit C, Vineland, NJ 08360 Phone: 856-690-1616 Fax: 856-896-6107 |